(CRSP) Crispr Therapeutics - Performance -3.2% in 12m

CRSP performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating -56.20%
#85 in Peer-Group
Rel. Strength 34.48%
#5052 in Stock-Universe
Total Return 12m -3.21%
#65 in Peer-Group
Total Return 5y -37.97%
#51 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward 23.4
High / Low USD
52 Week High 62.75 USD
52 Week Low 31.27 USD
Sentiment Value
VRO Trend Strength +-100 97.43
Buy/Sell Signal +-5 2.12
Support / Resistance Levels
Support
Resistance
12m Total Return: CRSP (-3.2%) vs XBI (-6.2%)
Total Return of Crispr Therapeutics versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (CRSP) Crispr Therapeutics - Performance -3.2% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
CRSP 11.7% 37.2% 59.7%
RGC 13.9% 43.4% 3,495%
VOR 115% 760% 224%
IPA 18.0% 132% 285%

Long Term Performance

Symbol 6m 12m 5y
CRSP 27.2% -3.21% -38%
RGC 0.0% 0.0% 8,221%
DRUG -28.8% 2,551% 5.07%
MNPR 57.8% 931% -11.0%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
GILD NASDAQ
Gilead Sciences
2.94% 73.2% 77.8% 22.7 13.6 0.23 28.3% -3.71%
UTHR NASDAQ
United Therapeutics
-9.16% -5.32% 147% 11.3 10.5 1.43 74.6% 16.1%
AMGN NASDAQ
Amgen
2.99% -0.49% 36% 25.4 13.4 0.93 0.60% 41%
BIM PA
Biomerieux
1.6% 32.8% -4.82% 33.1 25.8 1.55 -38.5% -25.1%
NBIX NASDAQ
Neurocrine Biosciences
3.29% -6.6% 1.14% 43 24.8 0.27 18.7% -34.3%
KMDA NASDAQ
Kamada
17.1% 57.4% -4.19% 25.5 22.8 0.91 48.1% 3.93%
PTCT NASDAQ
PTC Therapeutics
-3.2% 58.3% -9.25% 7.71 6.26 0.81 - 68%
ERF PA
Eurofins Scientific SE
3.23% 38.8% 14.5% 28.9 15.4 0.64 -62.1% -19.3%

Performance Comparison: CRSP vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRSP
Total Return (including Dividends) CRSP XBI S&P 500
1 Month 37.15% 3.53% 5.22%
3 Months 59.74% 9.10% 16.86%
12 Months -3.21% -6.17% 14.81%
5 Years -37.97% -24.21% 111.83%

Trend Score (consistency of price movement) CRSP XBI S&P 500
1 Month 93.2% 4.4% 81%
3 Months 68.8% 78.8% 96.9%
12 Months -70.9% -85.8% 44.9%
5 Years -81.6% -52.6% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month %th93.00 32.47% 30.34%
3 Month %th89.50 46.42% 36.69%
12 Month %th67.50 3.15% -15.70%
5 Years %th76.00 -18.16% -70.72%

FAQs

Does Crispr Therapeutics (CRSP) outperform the market?

Yes, over the last 12 months CRSP made -3.21%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%. Over the last 3 months CRSP made 59.74%, while XBI made 9.10%.

Performance Comparison CRSP vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

CRSP vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 9.5% 31.9% 20.9% -18%
US NASDAQ 100 QQQ 9.9% 31.6% 19.6% -17%
German DAX 40 DAX 10.5% 37.8% 7.4% -33%
Shanghai Shenzhen CSI 300 CSI 300 11.2% 32.9% 18.1% -22%
Hongkong Hang Seng HSI 10.5% 30.8% 2.5% -39%
India NIFTY 50 INDA 11.6% 33.8% 22.7% -3%
Brasil Bovespa EWZ 7.5% 28.9% -5.8% -15%

CRSP vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 10.2% 30.6% 16.2% -30%
Consumer Discretionary XLY 8.8% 34.3% 28.8% -22%
Consumer Staples XLP 9.2% 37.2% 21% -13%
Energy XLE 10.2% 32.2% 26.1% -1%
Financial XLF 9% 32.7% 16.9% -33%
Health Care XLV 10.8% 34.8% 28.8% 1%
Industrial XLI 8.9% 32.9% 13.9% -28%
Materials XLB 7.6% 32.5% 16.3% -9%
Real Estate XLRE 9.7% 35.9% 23.2% -16%
Technology XLK 9.4% 28.3% 17.8% -15%
Utilities XLU 10.9% 37.1% 19.5% -26%
Aerospace & Defense XAR 10.8% 29.5% 3.7% -52%
Biotech XBI 9.9% 33.6% 34.9% 3%
Homebuilder XHB 6.6% 28.6% 28.8% -8%
Retail XRT 6.5% 32.9% 25.5% -14%

CRSP vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 9.5% 29.6% 30.7% 4%
Natural Gas UNG 14.3% 47.2% 29.4% 4%
Gold GLD 11.6% 37.7% 1% -44%
Silver SLV 11.2% 30.6% 3% -24%
Copper CPER 11.1% 32.2% 2.3% -17%

CRSP vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 12.5% 34.5% 25.4% -2%
iShares High Yield Corp. Bond HYG 11.3% 35.4% 22.4% -14%